Legislative Advocacy

UsAgainstAlzheimer’s drives collaboration to overcome barriers to a cure for Alzheimer’s. They press for greater urgency from the government, industry, and the scientific community in the quest for a cure. They drive a continuum of collaboration to stop Alzheimer’s Disease with disease understanding, preclinical drug development, clinical trials and biomarkers, regulatory and access, big data and real-world evidence, market readiness, detection, and diagnosis.